Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 28;31(24):106564.
doi: 10.3748/wjg.v31.i24.106564.

Pay attention to the value of liver regeneration in the re-compensation of decompensated cirrhosis

Affiliations
Review

Pay attention to the value of liver regeneration in the re-compensation of decompensated cirrhosis

Jia-Ying Wang et al. World J Gastroenterol. .

Abstract

Conventional wisdom holds that progression from compensated cirrhosis to decompensated cirrhosis is irreversible in the natural history of the disease. However, in recent years, more and more clinical evidence suggests that liver cirrhosis can achieve re-compensation, that is, after effective etiological treatment and complication management, the liver function of partially decompensated patients with cirrhosis has improved and gradually stabilized, and decompensation no longer occurs for a long time. Liver regeneration, as one of the powerful intrinsic abilities of the liver, is the key to the restoration of the structure and complex physiological functions of the damaged liver. Studies have shown that the restoration of liver regeneration in patients with cirrhosis can promote the occurrence of re-compensation, thereby improving the prognosis of patients. At the same time, monitoring liver regeneration indicators is helpful in assessing patients' re-compensation potential for early selection of appropriate treatment options. Insufficient attention has been paid to the role of liver regeneration in the course of liver cirrhosis. Therefore, this article aims to review the value of liver regeneration in the re-compensation of decompensated cirrhosis.

Keywords: Decompensated cirrhosis; Liver regeneration; Prognosis; Re-compensation; α-fetoprotein.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors do not choose to declare any conflict of interest related directly or indirectly to the subject of this article.

Figures

Figure 1
Figure 1
Balance of hepatic regeneration pathways in patients with acute-on-chronic liver failure. ACLF: Acute-on-chronic liver failure; IL-6: Interleukin-6; IFN-γ: Interferon-γ.

Similar articles

References

    1. Emenena I, Emenena B, Kweki AG, Aiwuyo HO, Osarenkhoe JO, Iloeje UN, Ilerhunmwuwa N, Torere BE, Akinti O, Akere A, Casimir OE. Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis. Cureus. 2023;15:e39267. - PMC - PubMed
    1. Tsai FJ, Yang PY, Chen CJ, Li JP, Li TM, Chiou JS, Cheng CF, Chuang PH, Lin TH, Liao CC, Huang SM, Ban B, Liang WM, Lin YJ. Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan. BMC Complement Med Ther. 2020;20:221. - PMC - PubMed
    1. Chandna S, Zarate ER, Gallegos-Orozco JF. Management of Decompensated Cirrhosis and Associated Syndromes. Surg Clin North Am. 2022;102:117–137. - PubMed
    1. Premkumar M, Dhiman RK, Duseja A, Mehtani R, Taneja S, Gupta E, Gupta P, Sandhu A, Sharma P, Rathi S, Verma N, Kulkarni AV, Bhujade H, Chaluvashetty SB, Kalra N, Grover GS, Nain J, Reddy KR. Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program. Gastroenterology. 2024;167:1429–1445. - PubMed
    1. Wang Q, Zhao H, Deng Y, Zheng H, Xiang H, Nan Y, Hu J, Meng Q, Xu X, Fang J, Xu J, Wang X, You H, Pan CQ, Xie W, Jia J. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis. J Hepatol. 2022;77:1564–1572. - PubMed